Alison Moore
2018
In 2018, Alison Moore earned a total compensation of $1.8M as Chief Technical Officer at Allogene Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $102,124 |
|---|---|
| Option Awards | $1,401,225 |
| Salary | $233,265 |
| Other | $100,000 |
| Total | $1,836,614 |
Moore received $1.4M in option awards, accounting for 76% of the total pay in 2018.
Moore also received $102.1K in non-equity incentive plan, $233.3K in salary and $100K in other compensation.
Rankings
In 2018, Alison Moore's compensation ranked 6,178th out of 14,244 executives tracked by ExecPay. In other words, Moore earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,178 out of 14,244 | 57th |
Division Manufacturing | 2,360 out of 5,765 | 59th |
Major group Chemicals And Allied Products | 882 out of 2,128 | 59th |
Industry group Drugs | 739 out of 1,817 | 59th |
Industry Biological Products, Except Diagnostic Substances | 142 out of 339 | 58th |
Source: SEC filing on April 24, 2019.
Moore's colleagues
We found three more compensation records of executives who worked with Alison Moore at Allogene Therapeutics in 2018.
News
Allogene Therapeutics CEO David Chang's 2021 pay jumps 30% to $10M
April 26, 2022
Allogene Therapeutics CEO David Chang's 2020 pay falls 30% to $7.8M
April 22, 2021
Allogene Therapeutics CEO David Chang's 2019 pay slips 13% to $11M
April 23, 2020
Allogene Therapeutics CEO David Chang receives $13M in 2018
April 24, 2019